Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 1

Aeon Astron Europe B.V.

Publication list

= highlight article.

(A). Publications (2008-present: 42 SCI/SCIE publications)

Biocornea

1. Van Essen TH, van Zijl L, Possemiers T, et al. Biocompatibility of a fish

scale-derived artificial cornea: Cytotoxicity, cellular adhesion and

phenotype, and in vivo immunogenicity. Biomaterials. 2016;81:36-45.

(SCI/SCIE)

2. Chen SC, Telinius N, Lin HT, et al. Use of fish scale-derived BioCornea to

seal full-thickness corneal perforations in pig models. PLoS One.

2015;10(11):e0143511. (SCI/SCIE)

3. Hos D, van Essen TH, Bock F, et al. [Decellularized collagen matrix from

tilapia fish scales for corneal reconstruction (BioCornea)]. Ophthalmologe.

2014;111(11):1027-1032. (SCI/SCIE)

4. Yuan F, Wang L, Lin CC, Chou CH, Li L. A cornea substitute derived from

fish scale: 6-month followup on rabbit model. J Ophthalmol.

2014:914542.

5. Van Essen TH, Lin CC, Hussain AK, et al. A fish scale-derived collagen

matrix as artificial cornea in rats: Properties and potential. Investig

Ophthalmol Vis Sci. 2013;54(5):3224-3233. doi:10.1167/iovs.13-11799.

(SCI/SCIE)

6. Van Essen T, Lin C, Lai H, Hussain A, Luyten G, Jager M. A biocornea of fish

scales - First results of a research model. Acta Ophthalmol.

2011;89(s246):0-0.

7. Van Essen, T. et al. A biocornea of fish scales - First results of a research

model. Acta Ophthalmol. 89, (2011). (SCI/SCIE)

8. Lin, C. C. et al. A new fish scale-derived scaffold for corneal regeneration.

Eur. Cells Mater. 19, 50–57 (2010). (SCI/SCIE)

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 2

Biobone

1. Chou C-H, Chen Y-G, Lin C-C, Lin S-M, Yang K-C, Chang S-H. Bioabsorbable

fish scale for the internal fixation of fracture: a preliminary study. Tissue

Eng Part A. 2014;20(17-18):2493-2502. (SCI/SCIE)

ologen® Collagen Matrix

1. El-Sayyad F, El-Saied HMA, Abdelhakim MASE. Trabeculectomy with

Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year

Study. Ophthalmic Res. 2017. doi:10.1159/000456719. (SCI/SCIE)

2. Tanna AP, Rademaker AW, de Moraes CG, et al. Collagen matrix vs

mitomycin-C in trabeculectomy and combined phacoemulsification and

trabeculectomy: a randomized controlled trial. BMC Ophthalmol.

2016;16(1):217. (SCI/SCIE)

3. Fan KC, Guan H, Chaku M, Eliassi-rad B, Desai MA. Ologen versus

Mitomycin-C for Trabeculectomy in a Predominantly African American

Population. Glaucoma Open Access. 2016;1(1 :104):1-6.

4. Elhefney EM, Al-Sharkawy HT, Kishk HM, Abouelkheir H. Safety and efficacy

of collagen matrix implantation in infantile glaucoma. Eur J Ophthalmol.

2016;7:0. (SCI/SCIE)

5. Park KH, Kim JY, Choo SW, Yoon HY, Jeong SW. Ahmed glaucoma valve

implantation with Ologen Collagen Matrix for the surgical treatment of

feline glaucoma. Vet Ophthalmol. 2016:1-5. (SCI/SCIE)

6. Perez CI, Mellado F, Jones A, Colvin R. Trabeculectomy Combined With

Collagen Matrix Implant (Ologen). J Glaucoma. 2016;00(00):1. (SCI/SCIE)

7. Elmallah MH, Mohamed T, Elmahdy A. A comparative study between

trabeculotomy with deroofing of Schlemm’s canal augmented with Ologen

implant and conventional trabeculotomy in primary congenital glaucoma.

Delta J Ophthalmol. 2016;17:24-28.

8. Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T. Outcomes of

Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen

Implantation in Primary Advanced Glaucoma. J Glaucoma. 2016;00(00):1.

(SCI/SCIE)

9. Stephens JD, Sarkisian, Jr. SR. The use of collagen matrix (Ologen) as a

patch graft in glaucoma tube shunt surgery, a retrospective chart review.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 3

F1000Research. 2016;5:1898.

10. El-Saied H, Abdelhakim M. Trabeculectomy with ologen in secondary

glaucomas following failed trabeculectomy with MMC: comparative study.

Eye. 2016:1-9. (SCI/SCIE)

11. Dada T, Sharma R, Sinha G, Angmo D, Temkar S. Cyclodialysis-enhanced

trabeculectomy with triple Ologen implantation. Eur J Ophthalmol.

2016;26(1):95-97. (SCI/SCIE)

12. Cillino S, Casuccio A, Di Pace F, Cagini C, Ferraro LL, Cillino G.

Biodegradable collagen matrix implant versus mitomycin-C in

trabeculectomy: five-year follow-up. BMC Ophthalmol. 2016;16(1):24.

(SCI/SCIE)

13. 罗丹, 温跃春, 季青山. 小梁切除术分别联合Ologen植入与丝裂霉素C治疗青光眼的

有效性和安全性对比分析. 眼科新进展. 2016;36(2):175-177.

14. Wang X, Khan R, Coleman A. Device-modified trabeculectomy for glaucoma.

Cochrane Database Syst Rev. 2016;(12):583-592.

15. Menda SA, Lowry EA, Porco TC, Stamper RL, Rubin MR, Han Y. Ex-PRESS

outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. Int

Ophthalmol. 2015;35(3):357-363. (SCI/SCIE)

16. Cho C-H, Lee S-B. Biodegradable collagen matrix (OlogenTM) implant and

conjunctival autograft for scleral necrosis after pterygium excision: two

case reports. BMC Ophthalmol. 2015;15:140. (SCI/SCIE)

17. Rho S, Sung Y, Ma KT, Rho SH, Kim CY. Bleb analysis and short-term results

of biodegradable collagen matrix-augmented ahmed glaucoma valve

implantation: 6-month follow-up. Investig Ophthalmol Vis Sci.

2015;56(10):5896-5903.

18. Hafez M. Trabeculectomy with collagen matrix implantation versus

trabeculectomy with mitomycin C application for the treatment of primary

congenital glaucoma. J Egypt Ophthalmol Soc. 2015;108(2):26.

19. Gasanova NA. Pediatric glaucoma profile in Azerbaijan. Ophthalmol Russ.

2015;12(1):39-44.

20. Yuan F, Li L, Chen X, Yan X, Wang L. Biodegradable 3D-Porous Collagen

Matrix (Ologen) Compared with Mitomycin C for Treatment of Primary

Open-Angle Glaucoma: Results at 5 Years. J Ophthalmol. 2015. (SCI/SCIE)

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 4

21. Sorkhabi R, Fard AM, Poursayed Z, Veshagh M. Evaluating the Results of

Trabeculectomy with Collagen Matrix Compared with Mitomycin C and

Trabeculectomy without Adjuvant in Patients with Open-Angle Glaucoma.

Paripex-Indian J Res. 2015;4(5):22-26.

22. Jung JW, Kwon KY, Choi DL, Kim T-I, Kim EK, Seo KY. Long-term clinical

outcomes of conjunctival flap surgery for calcified scleromalacia after

periocular surgery. Cornea. 2015;34(3):308-312.

23. Hamdi M, Hamdi I. Scleral Repair by Biodegradable Collagen Implant in

Strabismus Surgery. Ophthalmol Res An Int J. 2015;3(4):141-146.

24. Ji Q, Qi B, Liu L, Guo X, Zhong J. Efficacy and Safety of Ologen Implant

Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of

Randomized Clinical Trials. J Glaucoma. 2015;24(5):e88-e94. (SCI/SCIE)

25. Niu W, Shen G, Yuan Y, et al. Biodegradable PTLGA Terpolymers versus

Collagen Implants Used as an Adjuvant in Trabeculectomy in Rabbit Eye. J

Ophthalmol. 2015;2015:1-9. (SCI/SCIE)

26. Tiwari S, B NVK, Shukla R, Pardhi P. Ologen and Pharmaceutical Elements

as Adjuvants in Trabeculectomy - Techniques and Results. Glaucoma - II

Free Pap. 2015:385-388.

27. Hamdi MM, Hamdi IM. Collagen Matrix Implant (Ologen)TM in Glaucoma

Surgeries; Precautions for a Better Control of Intraocular Pressure.

Ophthalmol Res An Int J. 2015;4(1):16-24.

28. Toh ZH, Lee CSY, Chew ACY, Perera S. Time Heals All Wounds: Obstacles in

Glaucoma Surgery from an Asian Perspective. Proc Singapore Healthc.

2015;24(2):103-112. (SCI/SCIE)

29. Voykov B, Rohrbach JM. Histopathological findings of a one-month old

Ologen implant. Clin Experiment Ophthalmol. 2015;43(6):604-605.

(SCI/SCIE)

30. Ichhpujani P, Dada T, Bhartiya S. Biodegradable Collagen Implants in

Trabeculectomy. J Curr Glaucoma Pr. 2015;9(1):24-27.

31. Rosentreter A, Gaki S, Cursiefen C, Dietlein TS. Trabeculectomy using

mitomycin C versus an atelocollagen implant: Clinical results of a

randomized trial and histopathologic findings. Ophthalmologica.

2014;231(3):133-140. doi:10.1159/000356400. (SCI/SCIE)

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 5

32. Gupta S, Wadhwani M, Sehgal V, Sharma S, Dada T. Blebitis with scleral

abscess in a case of operated trabeculectomy with mitomycin C and a

subcunjunctival ologen implant. Eye. 2014;28(3):354. (SCI/SCIE)

33. El-Malah MA, Shelil AE, GamalTahoon, Saleh MA, Galhoom AI, Ziada AGEHE

din A. A prospective comparative study between trabeculectomy alone

versus trabeculectomy with Ologen for patients with open angle glaucoma

two years follows up. Mohamed. J Am Sci. 2014;10(11):109-113.

34. 陈秀萍, 董春琼, 袁非. 翼状胬肉切除联合 ologen 植入术后三年随访。 中華全科醫

師雜誌. 2014;13(09):796-797.

35. Arish M. Nadjafi AN. Jahangard M. Collagen matrix implantation

following pterygium excision: outcomes of a preliminary tested hypothesis.

Med Hypothesis Discov Innov Ophthalmol. 2013;2(4):102-104.

36. Radhakrishnan OK, Pahuja K, Patel K, Chandna S. OLOGEN implant in the

management of glaucoma in an unusual case of Axenfeld-Rieger syndrome.

Oman J Ophthalmol. 2014;7(2):90-92.

37. He M, Wang W, Zhang X, Huang W. Ologen implant versus mitomycin C for

trabeculectomy: A systematic review and meta-analysis. PLoS One.

2014;9(1):1-9.doi:10.1371/journal.pone.0085782. (SCI/SCIE)

38. Johnson MS, Sarkisian SR. Using a Collagen Matrix Implant (Ologen) Versus

Mitomycin-C as a Wound Healing Modulator in Trabeculectomy With the

Ex-PRESS Mini Glaucoma Device: A 12-Month Retrospective Review. J

Glaucoma. 2013;23:649-652. (SCI/SCIE)

39. Dietlein TS, Lappas A, Rosentreter A. Secondary subconjunctival

implantation of a biodegradable collagen-glycosaminoglycan matrix to

treat ocular hypotony following trabeculectomy with mitomycin C. Br J

Ophthalmol. 2013;97(8). (SCI/SCIE)

40. Hamdi M. Trabeculectomy assisted by collagen matrix implant (Ologen) in

primary congenital glaucoma. J Egypt Ophthalmol Soc. 2013;106(3):

188-193. doi:10.4103/2090-0686.127398.

41. Tanuj D, Amit S, Saptorshi M, Meenakshi G. Combined subconjunctival and

subscleral ologen implant insertion in trabeculectomy. Eye.

2013;27(7):889. (SCI/SCIE)

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 6

42. Anguelov B. Ex-PRESS® and OlogenTM - single step implantation of two

implants with a different mechanism of action in glaucoma surgery. Bulg

Forum “Glaucoma.” 2013;3(5):224-239.

43. Anguelov B. Clinical cases of surgical revision with OlogenTM implantation

in eyes with glaucoma and Еx-PRESS¨ implant. Bulg Forum “Glaucoma.”

2013;3(4):173-182.

44. Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Comparison of

outcomes of trabeculectomy with mitomycin C vs. ologen implant in

primary glaucoma. Indian J Ophthalmol. 2013;61(7):338-342. (SCI/SCIE)

45. Razeghinejad MR, Fudemberg SJ, Spaeth GL. The changing conceptual

basis of trabeculectomy: A review of past and current surgical techniques.

Surv Ophthalmol. 2012;57(1):1-25. (SCI/SCIE)

46. Oana S, Vila J. Tube exposure repair. J Curr Glaucoma Pract.

2012;6(3):139-142.

47. Narayanaswamy A, Perera SA, Htoon HM, et al. Efficacy and safety of

collagen matrix implants in phacotrabeculectomy and comparison with

mitomycin C augmented phacotrabeculectomy at 1 year. Clin Exp

Ophthalmol. 2013;41(6):552-560. (SCI/SCIE)

48. Min JK, Kee CW, Sohn SW, Lee HJ, Woo JM, Yim JH. Surgical outcome of

mitomycin C-soaked collagen matrix implant in trabeculectomy. J

Glaucoma. 2013;22(6):456-462. (SCI/SCIE)

49. Marey HM, Mandour SS, Ellakwa AF. Subscleral trabeculectomy with

mitomycin-C versus ologen for treatment of glaucoma. J Ocul Pharmacol

Ther. 2013;29(3):330-334. (SCI/SCIE)

50. Dada T, Kusumesh R, Bali SJ, et al. Trabeculectomy With Combined Use of

Subconjunctival Collagen Implant and Low-dose Mitomycin C. J Glaucoma.

2012;22(8):1. (SCI/SCIE)

51. Anguelov B. Surgical treatment of some types of advanced glaucoma with a

single step implantation of two different implants - Ex-PRESS¨ and

OlogenTM. Bulg Forum “Glaucoma.” 2012;2(4):04-17.

52. Kohlhaas M. Trabekulektomie mit Mitomycin C und Ologen.

Ophthalmo-Chirurgie. 2012;24(1):19.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 7

53. Kasimov EM, Aghayeva FA. First results of the implantation of OlogenTM

collagen matrix in primary trabeculectomy. J Ophthalmol Azerbaijan.

2012;2(9):34-38.

54. De Peron R. The use of ologen collagen implant in traditional

trabeculectomy. Trib Medica Ticin. 2012;77:355-359.

55. Lee SJ, Woo JM, Min JK, Kee CW, Yim JH. The Analysis of The Clinical

Findings And Effects of Biodegradable Collagen Matrix in Trabeculectomy. J

Korean Ophthalmol Soc. 2012;53(2):297-305.

56. Cillino S, Di Pace F, Cillino G, Casuccio a. Biodegradable collagen matrix

implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month,

randomized clinical trial. Eye. 2011;25(12):1598-1606. (SCI/SCIE)

57. Nilforushan N, Yadegari M, Hodjat P. Comparison of the success rate of

trabeculectomy with Oculusgen versus trabeculectomy with mitomycin C.

Iran J Ophthalmol. 2011;23(4):03-12.

58. Sarkisian SR, Rouse JM. New methods and modifications of glaucoma

filtration surgery. Int Ophthalmol Clin. 2011;51(3):95-106.

59. Rosentreter A, Schild AM, Dinslage S, Dietlein TS. Biodegradable implant

for tissue repair after glaucoma drainage device surgery. J Glaucoma.

2012;21(2):76-78. (SCI/SCIE)

60. 申家泉 , 王聪 . 新生血管性青光眼研究进展 . 山东大学耳鼻喉眼学报 .

2011;25(5):92-94.

61. Tendulkar M, Jacobs NA, Ghosh YK. Modified trabeculectomy technique

called effective , quick , reproducible. Ocular Surgery News. 2011.

62. Radcliffe NM. Evolutions and Revolutions in Surgical Energy. Glaucoma

Today; 2011.

63. YAŞAR T. What’s New in Glaucoma Surgery. Glaucoma-Cataract.

2011;6(2):069-073.

64. Radcliffe NM. Evolutions and Revolutions in Surgical Energy. Glaucoma

Today. Published 2011.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 8

65. Rosentreter A, Schild a M, Jordan JF, Krieglstein GK, Dietlein TS. A

prospective randomised trial of trabeculectomy using mitomycin C vs an

ologen implant in open angle glaucoma. Eye (Lond).

2010;24(9):1449-1457. (SCI/SCIE)

66. Rosentreter A, Mellein AC, Konen WW, Dietlein TS. Capsule excision and

OlogenTM implantation for revision after glaucoma drainage device surgery.

Graefe’s Arch Clin Exp Ophthalmol. 2010;248(9):1319-1324.

67. Boey P-Y, Narayanaswamy A, Zheng C, et al. Imaging of blebs after

phacotrabeculectomy with Ologen collagen matrix implants. Br J

Ophthalmol. 2011;95(3):340-344. (SCI/SCIE)*

68. Costin D, Constantin C, Bucatariu MP, Mousa A al, Moraru AD. Combined

mechanism glaucoma asociated with Grave ’ s Ophtalmopathy. Case report.

Rom Neurosurg. 2010;XVII(3):364-373.

69. Nilforushan N, Yadgari M, Falavarjani KG, Afshar AE. Evaluation of

Subconjunctival Oculusgen Implantation as an Adjunct to Trabeculectomy.

Iran J Ophthalmol. 2010;22(2):55-62.

70. Sarkisian SR. A Replacement for Antimetabolites? Ologen is a new product

that modulates wound healing in glaucoma surgery. Glaucoma Today.

2010.

71. Papaconstantinou D, Georgalas I, Karmiris E, et al. Trabeculectomy with

OloGen versus trabeculectomy for the treatment of glaucoma: A pilot

study*. Acta Ophthalmol. 2010;88(1):80-85.

72. Anguelov B. Trabeculectomy with absorbable suture of the scleral flap and

subconjunctival biodegradable collagen matrix implant (ologenTM) in

primary open angle glaucoma. Ref Bul Ophthalmol. 2010;1:21-28.

73. Hong SJ, Lee JR, Choi JY, Choi JW, Kim YD. Trabeculectomy With

Biodegradable Collagen Material: A Report of Two Cases. J Korean

Ophthalmol Soc |. 2010;52(6):912-918.

74. Hong S, Lee JR, Kim Y-D, Choi JY, Choi J. Fibrous Encapsulation of

Biodegradable Collagen Matrix After Trabeculectomy: A Case Report. J

Korean Ophthalmol Soc. 2010;51(4):631-635.

75. Rao K, Ahmed I, Blake D a, Ayyala RS. New devices in glaucoma surgery.

Expert Rev Ophthalmol. 2009;4(5):491-504. (SCI/SCIE)#

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 9

76. Anguelov B. Phacotrabeculectomy with absorbable suture of the scleral flap

and subconjunctival biodegradable collagen matrix implant (ologenTM) in

eyes with a cataract and primary open angle glaucoma. Ref Bul Ophthalmol.

2009;6:17-26.

77. Anguelov B. Trabeculectomy with absorbable suture of the scleral flap and

subconjunctival biodegradable collagen matrix implant (ologenTM) in

refractory glaucoma. Ref Bul Ophthalmol. 2009;5:23-30.

78. Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence

tomography imaging of filtering blebs after deep sclerectomy with new

collagen implant. Eur J Ophthalmol. 2009;19(2):223-230. (SCI/SCIE)*

79. Dietlein TS, Jordan J, Lueke C, Krieglstein GK. Modern concepts in

antiglaucomatous implant surgery. Graefe’s Arch Clin Exp Ophthalmol.

2008;246(12):1653-1664.

80. 陈秀萍, 袁非, 陈旭, 马晓萍, 黎蕾. 胶原蛋白基质在非穿透性小梁切除术中的应用.

中国临床医学. 2008;15(No. 5):705-707.

81. Dietlein TS, Jordan J, Lueke C, Krieglstein GK. Modern concepts in

antiglaucomatous implant surgery. Graefe’s Arch Clin Exp Ophthalmol.

2008;246(12):1653-1664.

82. Zelefsky JR, Hsu W, Ritch R. Biodegradable collagen matrix implant for

trabeculectomy. Expert Rev Ophthalmol. 2008;3(6):613-617. (SCI/SCIE)

83. Kohlhaas M. Postoperative Risks in Previously Operated Eyes are Lowered.

Trabeculectomy With mitomycin C and ologenTM Implant. Ophthalmol

Nachrichten. 2008.

84. Hsu WC, Ritch R, Krupin T, Chen HSL. Tissue bioengineering for surgical

bleb defects: An animal study. Graefe’s Arch Clin Exp Ophthalmol.

2008;246(5):709-717.

85. Tope A, Mermoud A, Shaarawy J. Glaucoma 2007. Ophthalmol Times

Eur.:33-39.

86. Ritch R. Using Bioengineered Collagen Matrix During

Trabeculectomy-Biodegradable polymer implants show promise for

improving the function of filtering blebs. Glaucoma Today. 2007.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 10

Footnotes:

* OculusGenTM used in the study is the prototype brand name and has

been renamed into ologen® Collagen Matrix in July 2007 with enhanced

biocompatibility, longer biodegradation time in accordance with the wound

healing process, and more pressure sustainability and resistance to

humidity. “ologen® Collagen Matrix” has also improved for better

performance and efficacy in terms of IOP control and overall surgical

outcomes, which can be shown in the preliminary meta-analysis based on

the SCI publications available to date. The meta-analysis publications will

be reviewed and published some time in the future.

# In this review, all the references cited under Oculusgen collagen implant

were originally referred to ologen® Collagen Matrix.

(B). Scientific program (content available upon request)

1. The congress of the European Society of Ophthalmology(SOE), June 6 – 9,

2015, Vienna.

Aleksandra Wlaź, Agnieszka Wilkos-Kuc, Agnieszka Rozegnał-Madej,

Tomasz Żarnowski; Evaluation of the efficacy of colagen matrix

implants (Ologen® ) in comparison with mitomycin C for intraocular

pressure reduction in phacotrabeculectomy

2. The 119th JOS(日本眼科学会总会), April 16-19, 2015 in Sapporo, Japan

千照会・千原眼科 千原悦夫、林 妍;多孔性インプラント Ologen を用いた

緑内障手術の成績

3. The 5th International Forum of Ophthalmic Surgery; 2015, Katowice,

Poland

A. Bakunowicz-Lazarczyk, B. Urban: Ologen insertion in

trabeculectomy in children-preliminary report.

4. The 4th Asia Cornea Society Scientific Meeting(ACS), Dec. 11 – 12 2014,

Nov4-7, 2014 Taipei, Taiwan.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 11

KoHua Chen: Fish scale collagen as feeder layer for corneal

endothelial cell-sheet preparation.

5. The 2014 American Academy of Ophthalmology(AAO); Oct. 18-21,

Chicago, U.S.A.

S. Sarkisian: Preventing scarring in Glaucoma Filtration Surgery.

S. Vold: Micro invasive Glaucoma Surgery into Clinical Practice.

6. The 2014 World Ophthalmology Congress; Apr 2-5, 2014, Tokyo, Japan.

ologen® Collagen Matrix And Wound Healing Modulation In Eye Surgery.

Hall D5, Tokyo Intl Forum on Apr 3, 2014. Moderator: Robert Ritch

Angelo Tanna: An RCT in USA: ologen® Collagen Matrix vs. MMC in

Trabeculectomy- The One-Year Interim Results

Salvatore Cillino: ologen® Collagen Matrix vs. MMC in Trabeculectomy- A

Five-Year Update

Steven Sarkisian: Collagen Matrix Implant As A Wound Modulator in

Trabeculectomy With The Ex-PRESSTM Mini Glaucoma Device

Zaher Sbeity: Bleb Revision Surgery and ologen® Collagen Matrix

Kyoung Yul Seo: The Repair of Scleral Thinning With ologen® Collagen

Matrix

7. The 2013 World Glaucoma Congress; Jul 18-20, 2013, Vancouver, Canada.

New Horizons: Novel Applications for ologen Collagen Matrix. Room 202 &

203 on Jul 18. Moderator and audience response: D Godfrey.

D Godfrey: ologen Collagen Matrix: the US experience

S Vold: the Ex-Press ologen technique

R Fellman: painful bleb? Revision surgery and ologen CM.

N Hasanova: case report: ologen CM in congenital glaucoma

M Moussalli: keys to Success with logen CM in trabeculectomy and

NPDS

8. The 2013 APAO-AIOS Congress; Jan 17-20, 2013, Hyderabad, India.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 12

Breakfast Debate: “ologen Collagen Matrix or MMC for Glaucoma Surgery?

(GL-SP01)” Hall 9 on Jan 18. Moderator and audience response: R Ritch.

L Vijaya, B S Rao (MMC vs. ologen). Fundamental wound modulation

methodology and significance in clinical outcomes: bleb morphology,

complications, revision.

Sathyan P, S Sirisha (ologen vs. MMC). Safety and efficacy in

randomized controlled trials and enabling surgical tips.

R Ritch. The Use of ologen in Filtration Surgery (GL-SS08).

9. The 2012 EGS Congress; Jun 17-22, 2012, Copenhagen, Denmark. Room

Harlekin on June 19.

H J Schuitmaker. Overview of ologen® Collagen Matrix.

T S Dietlein. ologen® for surgical treatment of exposed tubes after

GDD surgery.

10. The 16th AFRO Asian Congress of Ophthalmology; Jun 13-16, 2012,

Istanbul. Ağustos Zafer Hall. Session: GLAUCOMA (CRS5) on June 13.

Tharwat Mokbel. Trabeculectomy with ologen.

11. The 2012 APAO/SOE Joint Meeting; April 13-16, 2012, Busan, Korea.

Booth 807

S B, Lee. ologen Collagen Matrix in repair of sclera thinning.

A, Rakib. ologen Collagen Matrix in pterygium excision.

J H, Son. ologen Collagen Matrix in oculoplastic surgery (DCR &

socket reconstruction etc).

S Noman. ologen Collagen Matrix in trabeculectomy (complicated

and secondary glaucoma cases).

12. The 2012 World Ophthalmology Congress (WOC); Feb 16- 20, 2012, Abu

Dhabi, United Arab Emirates.

Symposium: A Replacement for MMC? Expo Theatre.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 13

R. Ritch. Novelty design of ologen® Collagen Matrix to improve

surgical success rate without MMC.

S. Cillino. A 2-year randomized study of ologen® Collagen Matrix vs

MMC.

S. Sarkisian. Recent advances in glaucoma surgery - Clinical

experiences of ologen® Collagen Matrix in over 1000 ocular surgeries.

Z. Sbeity. ologen® Collagen Matrix in revision of filtering surgery.

P. Sathyan. Experiences & practical tips of ologen® Collagen Matrix in

Indians.

S. Rao. ologen® Collagen Matrix in developing countries – A

replacement for MMC?

Scientific Programs:

Z. Sbeity. ologen® Collagen Matrix in revision filtering surgery: is it

useful? IS-GLA-TH 28 Hall 11. Symposium on “Advanced” by MEAGS.

S. Sarkisian. ologen® Collagen Matrix implant. IS-GLA-FR 57 Hall 11.

Symposium on “Recent Advances in Glaucoma Surgery” by WGA.

P. Sathyan. Changing Trends in Trabeculectomy Video Assisted Skill

Transfer Course. CO-GLA-SA 200 Capital Suite 4. Instruction Course:

Glaucoma.

S. Wisam. Efficacy of ologen matrix implant in Jordan. IS-GLA-SU

253 Hall 11. Symposium on “Managing Glaucoma in Developing

Countries” by Ophthalmological Society of Pakistan (OSP).

Khalil Errais. Pterygium Surgery: How to Avoid Recurrence.

IS-VID-MO 351 Hall 12. Symposium on “Cornea and Ocular Surface

Diseases”

13. The 2011 World Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris.

J. Lin. Can MMC be replaced: Collagen matrix for eye tissue repair. R

341. Introduction of ologen® Collagen Matrix.

S. Cillino. Can MMC be replaced: Collagen matrix for eye tissue repair.

R 341. Biodegradable collagen matrix implant vs. mitomycin-C as an

adjuvant in trabeculectomy: A two-year randomized clinical trial.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 14

J. Lai. Can MMC be replaced: Collagen matrix for eye tissue repair. R

341. Trabeculectomy with ologen® and MMC.

P. Sathyan. Can MMC be replaced: Collagen matrix for eye tissue

repair. R 341. Trab with ologen® : The practical tips for the better

outcome and the Indian experience.

14. The 2010 World Ophthalmology Congress (WOC); June 5-9, 2010, Berlin.

Kohlhaas M. Can MMC be replaced: ologen® for eye tissue repair. H9.

500 experiences with ologen® collagen matrix in trabeculectomy.

Ni J. Can MMC be replaced: ologen® for eye tissue repair. H9.

Introduction of ologen®

Campos EC. Can MMC be replaced: ologen® for eye tissue repair. H9.

Use of ologen® collagen matrix in strabismus surgery

15. The 5th International Congress on Glaucoma Surgery (ICGS); November

11-13, 2010, New Delhi, India.

Rao BS. Plenary Session 1-Trabeculectomy: The state of the art.

PL1.5: Improving success of trabeculectomy.

Sharmila R. Plenary session 6-Wound Healing: The eye under control.

PL6.5: Trabeculectomy with subconjunctival biodegradable implant

(ologen) for the treatment of glaucoma.

Singh K. Plenary session 6-Wound Healing: The eye under control.

PL6.7: Collagen implant in trabeculectomy: our experience.

Kusumesh R. Plenary session 6-Wound Healing: The eye under

control. PL6.8: Outcome of trabeculectomy with combined use of

subconjunctival collagen implant and mitomycin c.

Aung T. Plenary Session 9-New Surgical Options: Looking ahead.

PL9.6: ologen implants for Phacotrabeculectomy.

Ariga M, Crowston J. Instruction Course 10 (basic)-Wound healing:

Practical considerations.

16. The 2008 ASCRS-ASOA Symposium and Congress; April 4-9, 2008,

Chicago, USA.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 15

Grewal SPS, Jain R, Grewal D, Brar GS. Safety and Efficacy of

OculusGen** Biodegradable Collagen Matrix Implant in

Phacotrabeculectomy Surgery.

(C). Conference papers and presentations (2008-present)

Biocornea

1. KoHua Chen, The preparation scale collagen as feeder layer for corneal

endothelial cell-sheet for DSAEK graft. 4th Asia Cornea Society Scientific

Meeting(ACS), Dec. 11 – 12 2014, Taipei, Taiwan.

2. KoHua Chen, The preparation scale collagen as feeder layer for corneal

endothelial cell-sheet for DSAEK graft. 7th World Congress on Preventive

and Regenerative Medicine (WCPRM),Nov4-7, 2014 Taipei, Taiwan.

3. Van Essen TH, Lin CC, Lai HJ, Hussain AK, Jager MJ, Luyten GPM. A

Biocornea Of Fish Scales - First Results Of A Research Model. 6038/D859

ARVO annual meeting; May 6-10, 2012, Ft. Lauderdale, USA.

4. Hos D, Bock F, Regenfuss B, Onderka J, Lin CC, Lai HJ, Cursiefen C.

Reduced Hem- And Lymphangiogenesis Into A Fishscale-derived Collagen

Scaffold Used As Biological Artificial Cornea (BioCornea). 040/D861. ARVO

annual meeting; May 6-10, 2012, Ft. Lauderdale, USA.

5. Julio Lin. Biocornea: Fish scale as a scaffold for corneal regeneration.

2012 WOC; Feb 16- 20, 2012, Abu Dhabi, United Arab Emirates.

6. Lin CC, Ritch R, Lin SM, Ni MH, Chang YC, Lin FH. Biocornea: A New Fish

Scale-derived Scaffold for Corneal Regeneration. The 25th APAO-AAO Joint

Congress; September 16-20, 2010, Beijing, China.

7. Lin CC, Ritch R, Lin SM, Ni MH, Chang YC, Lai HJ, Lin FH. The ARVO 2010

Annual Meeting; May 2-6, 2010, Fort Lauderdale, USA.

8. Van Essen TH, Lin CC, Lai HJ, Hussain AK, Luyten GPM, Jager MJ. A

biocornea of fish scale- evaluation of a research model. PNO 4088,

Association for Research in Vision and Ophthalmology annual meeting;

May 1 – 5, 2011, Fort Lauderdale, USA.

ologen® Collagen Matrix

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 16

1. N. M-H Azerbaijan, E. Kasimov, J. Hasanov. Combined trabeculotomy:

trabeculectomy with collagen matrix implant in secondary childhood

glaucoma. The European Society of Cataract and Refractive

Surgery(ESCRS); 2014, Sep 13-17, London, UK

2. Henry Chen. Follow-up for Trabeculectomy with Biodegradable 3D porous

Collagen-GlycosaminoglycanMatrix (ologen) for Treatment of High

Myopic Glaucoma. APGC-ISOHK 2014; Sep. 26-28, Hong Kong.

3. Nafees Baig, Nancy SY Yuen, Clement CY Tham. A prospective randomized

controlled trial comparing non-penetrating deep sclerectomy and

mitomycin-C with or without Ologen implant – 1-year follow-up results.

APGC-ISOHK 2014, Sep. 26-28, Hong Kong.

4. Sangchul Yoon, Ji Min Ahn, Kyoung Yul Seo_Safety and Effectiveness of

Biodegradable Implant (ologen® ) with Conjunctival Sliding Flap Surgery

for Calcified Scleromalacia. ARVO 2014. Oct. 7 - 10, Fort Lauderdale,

Florida. Asia-AR.

5. Tran Anh Tuan, Trinh Bach Tuyet, Bui Thi Thu Huong, To Ky Anh, Nguyen

Hoang Phuc. Trabeculectomy with Ologen™ (OLO) versus trabeculectomy

with mitomycin - C (MMC) for the treatment of glaucoma: a 6-month,

randomized clinical trial. The AOS 2014, July 9-11, Bangkok.

6. Dewang Angmo. P3165 Outcomes of Combined subconjunctival with

subscleral Ologen implant in glaucoma filtering surgery. The ARVO 2014;

MAY 4 - 8, 2014, ORLANDO, FLORIDA.

7. Yasser Hamed. PO620 Biodegradable Collagen Matrix (Ologen) with Low

Dose Mitomycin C in High Risk Cases and Post Failed Trabeculectomy. The

2014 WOC; Apr 2-5, Tokyo.

8. Fidan Aghayev. P0658 Trabeculectomy with Ologen® Collagen Implant vs

Trabeculectomy with Mitomycin C and Cohesive Viscoelastic in Steroid

Induced Glaucoma. The 2014 WOC; Apr 2-5, Tokyo.

9. Nigar Hasanova. VI-75 Combined Trabeculotomy with Trabeculectomy

with Subconjunctival Collagen Matrix Implant in Child with Ched and

Glaucoma. The 2014 WOC; Apr 2-5, Tokyo.

10. Babak Eliassi-Rad. PO678 Use of Collagen Matrix (Ologen) as an Adjunct

with Trabeculectomy or Phacotrabeculectomy. The 2014 WOC; Apr 2-5.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 17

11. Yuan Fei. PO286 The Efficacy and Safety of the Oculusgen (ologen)

Collagen Matrix Implanted During Surgical Excision of Primary Pterygium.

The 2014 WOC; Apr 2-5, Tokyo.

12. Momen Hamdi. PO538 Collagen Matrix Implant (Ologen) in Glaucoma

Surgeries; Precautions for a Better Control of Intraocular Pressure. The

2014 WOC; Apr 2-5, Tokyo.

13. Momen Hamdi. PO703 Trabeculectomy with Collagen Matrix Implant

(Ologen) in Primary Congenital Glaucoma. The 2014 WOC; Apr 2-5,

Tokyo.

14. John Stevens. P16 Collagen Matrix (Ologen) as a Patch Graft in Glaucoma

Tube Shunt Surgery. The 2014 AGS; Feb 27-Mar 1, Washington DC.

15. Oluwatosin Smith, David Godfrey, Davinder Grover, Michelle Butler,

Ronald Fellman. P40 Surgical Outcomes Following the Use of a

Biodegradable Subconjunctival Collagen-Glycosaminoglycan Matrix in

Revisions of Late-Onset Glaucoma Filtering Bleb Leaks. The 2014 AGS;

Feb 27-Mar 1, Washington DC.

16. D. Angmo, S. Temkar, T. Dada. P81 Outcomes of combined

subconjunctival with subscleral Ologen implant in glaucoma filtering

surgery. ICGS 2014; February 20-22, 2014, Singapore.

17. L. Pelosini, E. Ansari. P92 Trabeculectomy revision with Ologen implant.

ICGS 2014; February 20-22, 2014, Singapore.

18. M. Moussalli. P93 Keys to success when using ologen in glaucoma

surgery: trabeculectomy and non penetrating deep sclerectomy. ICGS

2014; February 20-22, 2014, Singapore.

19. Nigar Hasanova, Jamil Hasonov. PA054 Comparative Evaluation of

Combined Trabeculotomy-Trabeculectomy vs. Combined

Trabeculotomy-Trabeculectomy With Subconjunctival Implantation of

Collagen Matrix Implant for Primary Congenital Glaucoma. The 2013 AAO;

Nov 16-19, New Orleans, USA.

20. Sangchul Yoon, Kyoung Yul Seo. P116 Biodegradable implant for tissue

repair for scleromalacia treatment. The 2013 Annual Meeting of the

Korean Ophthalmological Society (KOS), Nov 1-3, Seoul, Korea.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 18

21. Eun Young Cho, Sang-Bumm Lee. P277 Novel Surgical Therapy Using

Biodegradable Collagen Matrix for Ocular Surface Reconstruction of

Scleral Thinning after Pterygium Excision. The 2013 KOS, Nov 1-3, Korea.

22. N. Baig, N. Yuen. P300 A Pilot Study of the Use of ologen in

Nonpenetrating Deep sclerectomy with MMC. The 2013 WGC; JuL 18-20,

Vancouver, Canada.

23. N. Hasanova, J. Hasanov, E. Qasimov. P336 Evaluation of Subconjunctival

Collagen Matrix Implant as An Adjunct to Combined Trabeculotomy-

Trabeculectomy in Congenital Glaucoma. The 2013 WGC; JuL 18-20,

Vancouver, Canada.

24. S. Noman. P391 Filtration Surgery – Trabeculectomy Vesus

Trabeculectomy With ologen for the Treatment of Glaucoma: A Pilot Study.

The 2013 WGC; JuL 18-20, Vancouver, Canada.

25. D. Pal, S. Chakraborty, J. Sengupta, R. Choudhary, A. Ganguly. P399

Preliminary Result of Trabeculectomy with Biodegradable Collagen Matrix

Implant in Pseudophakic Glaucoma with Myopia. The 2013 WGC; JuL

18-20, Vancouver, Canada.

26. J.H. Yim, J.H. An, H.J Cha, J.K Min. P449 Efficacy of MMC Soaked

Biodegradable Collagen Matrix Implant as A Wound Healing Modulator in

Trabeculectomy. The 2013 WGC; JuL 18-20, Vancouver, Canada.

27. Hamdi M. EP-GLA-310 Trabeculectomy with collagen matrix implant

(Ologen) in primary congenital glaucoma. The 2013 EGS Meeting; June

7-11, Copenhagen, Denmark.

28. Hamdi M. EP-GLA-311 Collagen matrix implant (Ologen) in glaucoma

surgeries; precautions for a better control of intraocular pressure. The

2013 EGS Meeting; June 7-11, Copenhagen, Denmark.

29. Marey H, Mandour S, Ellakwa A. EP-GLA-385 Subscleral trabeculectomy

with mitomycin-C versus ologen for treatment of glaucoma. The 2013 EGS

Meeting; June 7-11, Copenhagen, Denmark.

30. Dipanjan Pal, Jayangshu Sengupta. Preliminary result of trabeculectomy

with biodegradable implant in pseudophakic glaucoma with myopia. The

2013 ASCRS-ASOA Meeting; Apr 20-23, 2013, San Francisco, USA.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 19

31. Shrikant Waikar, VK Srisvstava. Management of recurrent symblepharon

with pterygium using collagen matrix scaffold implant with autologous

limbal stem cell graft. EP-0351, The 2013 APAO-AIOS Congress; Jan

17-20, 2013, Hyderabad, India.

32. Shilpa N. One year outcome of trabeculectomy with ologen. EP-0540, The

2013 APAO-AIOS Congress; Jan 17-20, 2013, Hyderabad, India.

33. Shivali M, Robert LS, Ayman N, Michel RR, Ying H. Outcomes With the

Ex-PRESS Mini Shunt Using Mitomycin C, ologen With 5-FU, and ologen

Alone. The 2012 AAO/APAO Joint Meeting; Nov 10-13, 2012, Chicago,

USA.

34. Bordeianu C. Medium-term results after trabeculectomy on scarred

conjunctiva, using fibrogenesis modulators (ologen) and fibrogenesis

inhibitors (5-FU). The XXX Congress of ESCRS; September 7-12, 2012,

Milan, Italy.

35. Hamed Y. Biodegradable collagen matrix (ologen) with low dose

mitomycin-C in bleb revision cases post failed trabeculectomy. The XXX

Congress of ESCRS; September 7-12, 2012, Milan, Italy.

36. M. Siddig. Collagen matrix implant for treatment of refractory glaucoma

(ologen) in 25 pt in Sudan. P45. The 6th ICGS; Sept 13-15, 2012, Glasgow,

UK.

37. L. Pelosini, E. Ansari. Ologen biodegradable collagen matrix implant for

trabeculectomy revision surgery: a pilot trial. P78. The 6th ICGS; Sept

13-15, 2012, Glasgow, UK.

38. Dietlein TS, Rosentreter A. Secondary subconjunctival implantation of

biodegradable porous collagen matrix for treating ocular hypotony

following trabeculectomy with mitomycin C. P 5.10 2012 EGS Congress;

Jun 17-22, Copenhagen, Denmark.

39. Kouros P, Loesche C C, Sbeity Z, Palmiero PM. ologen implants as an

adjuvant for revision surgery after failed trabeculectomy. P 5.22 2012

EGS Congress; Jun 17-22, Copenhagen, Denmark.

40. Matthew S J, Sarkisian S, Nathan B, James M R. Initial experience using a

collagen matrix implant (ologen) as a wound modulator with canaloplasty:

12 month results. 203 Glaucoma: surgery or wound healing – GL. 2012

ARVO; May 6-10, Ft. Lauderdale, USA.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 20

41. Rosentreter A, Konen W, Dietlein TS, Hermann M. Histopathologic findings

in explanted ologen Implants. 203 Glaucoma: surgery or wound healing –

GL. 2012 ARVO; May 6-10, Ft. Lauderdale, USA.

42. Wisam S. The Outcome of Trabeculectomy Using a Collagen Matrix

Implant. FP-GLA-MO 397 Free Paper: Glaucoma. The 2012 WOC; Feb 16-

20, 2012, Abu Dhabi, UAE.

43. Sathyan P. Type I collagen matrix (ologen) implant with trabeculectomy-

control 2 chambers with one sponge. VI-GLA-10 Video Presentations:

Glaucoma. The 2012 WOC; Feb 16- 20, 2012, Abu Dhabi, UAE.

44. Shobaki A. Deep sclerectomy with ologen implant. VI-GLA-15 Video

Presentations: Glaucoma. The 2012 WOC; Feb 16- 20, 2012, UAE.

45. Walimbe T. Combined small incision cataract surgery with trabeculectomy

with ologen implant. VI-GLA-24 Video Presentations: Glaucoma. The 2012

WOC; Feb 16- 20, 2012, Abu Dhabi, UAE.

46. Maragatham K. ologen implant in primary trabeculectomy. Hall D. 59th

Annual Conference of the Tamil Nadu Ophthalmic Association. Aug 05 –

Aug-07 2011, Tamil Nadu, India.

47. Alagatta SD, Sasi Kumar R, Rao D, Shetty B. Safety and efficacy of

ologenTM implant and adjunctive mitomycin C in trabeculectomy in Asian

Indian eyes with advanced glaucoma. P567. The 2011 World Glaucoma

Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

48. Shihadeh W, Alwattar B. The outcome of trabeculectomy using a collagen

matrix implant (ologen). P569. The 2011 World Glaucoma Congress

(WGC); Jun 29 – Jul 2, 2011, Paris, France.

49. Chen HS, Hsu W. Three-year Follow-up of Trabeculectomy with

Biodegradable 3D Porous Collagen-Glycosaminoglycan Scaffold for

Treatment of Refractory Glaucoma. P634. The 2011 World Glaucoma

Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

50. Kee MJ, Ho YJ, Changwon K. Clinical experience of mytomycin-C soaked

collagen matrix implant in trabeculectomy. P636. The 2011 World

Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 21

51. Wiyogo WA. Trabeculectomy using biodegradable collagen matrix implant

in chronic primary glaucoma patients. P644. The 2011 World Glaucoma

Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

52. Ali SI. Study of the safety and effectiveness between ologenTM collagen

matrix implant and mytomycin-C in standard glaucoma filtration surgery.

P648. The 2011 World Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011,

Paris, France.

53. Ezpeleta Campana J A, Muniesa Royo M J, Jurjo Campo C, Traveset Maeso

A, Sanchez Perez C. Effectiveness of the Ex-Press Mini Glaucoma Shunt in

the Treatment of Primary Open-Angle Glaucoma. P697. The 2011 World

Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

54. Kirilova Y, Hergeldzhieva-Fileva T, Vassileva P. Control of Intraocular

Pressure in Secondary Glaucoma. GS8. The 2011 World Glaucoma

Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.

55. Rosentreter A, Schild AM, Gaki S, Mellein AC, Dietlein TS. The ARVO 2011

Annual Meeting; May 1-5, 2011, Fort Lauderdale, USA.

56. Rouse JM, Sarkisian SR. Trabeculectomy Using Collagen Matrix Implant: A

retrospective Review on 1-Year Data. AGS, 21st Annual Meeting; March

3-6, 2011, Dana Point, California, USA.

57. Rao BS. Ologen as an adjunct in refractory glaucoma surgery. The 25th

APAO-AAO Joint Congress; September 16-20, 2010, Beijing, China.

58. Tzvetkova B, Anguelov B. The 9th Congress of the EGS; September 12-17,

2010, Madrid, Spain.

59. Jin Ho Y, Chul Min K, Changwon K. The 9th Congress of the EGS;

September 12-17, 2010, Madrid, Spain.

60. Rosentreter A, Mellein AC, Konen WW, Dietlein TS. P-TU-066 Capsule

Excision and ologen Implantation for Revision After Glaucoma Drainage

Device Surgery. WOC 2010; June 5-9, Berlin, Germany.

61. Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS. A

Prospective Randomized Trial of Trabeculectomy Using Mitomycin C vs. an

Ologen Implant in Open Angle Glaucoma. The ARVO 2010 Annual Meeting;

May 2-6, 2010, Fort Lauderdale, USA.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 22

62. Htoon HM, Boey P-Y, Narayanaswamy A, Zheng C, Perera SA, Wong TT,

Aung T. Imagining of Blebs After Phacotrabeculectomy With Ologen

Collagen Matrix Implants. The ARVO 2010 Annual Meeting; May 2-6, 2010,

Fort Lauderdale, USA.

63. Chen HSL, Hsu WC. Trabeculectomy With Biodegradable Porous

Collagen-Glycosaminoglycan Matrix Implant for Treatment of Refractory

Glaucoma. AAO-PAAO Joint Meeting; Oct 24-27, 2009, San Francisco,

USA.

64. Ogle J, Lim BA. 12.8.5 Surgical Treatment: Filtering surgery: Other. WGC

2009; July 8-11, 2009, Boston, USA.

65. Sumantri W. 12.8.10 Surgical Treatment: Filtering surgery:

wound-healing antifibrosis. WGC 2009; July 8-11, 2009, Boston, USA.

66. Narayanaswamy KA, Seah SK, Perera SA, Wong TT, Hoh ST, Aung T.

12.14.3 Surgical Treatment: Combined cataract extraction and glaucoma

surgery: Phacoemulsification. WGC 2009; July 8-11, 2009, Boston, USA.

67. Chen HS-L, Hsu W-C. 12.8.2 Surgical Treatment: Filtering surgery: With

tube implant or other drainage devices. WGC 2009; July 8-11, 2009,

Boston, USA.

68. Chen H. EH2-352 Trabeculectomy With Biodegradable 3D Porous

Collagen-Glycosaminoglycan Scaffold for Treatment of Refractory

Glaucoma. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,

Indonesia.

69. Prihatningtias R, Sadasih W, Rahmi F. EN1-039 The Comparison Between

ologen Collagen Matrix Implant & Mitomycin-C in the Glaucoma Filtration

Surgery. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,

Indonesia.

70. Sadasih W. EN1-043 The Comparison Between ologen Collagen Matrix

Implant & Mitomycin-C in the Glaucoma Filtration Surgery. The 24th

APAO-AAO Joint Congress; May 16-19, 2009, Bali, Indonesia.

71. Ali I, Butt N. EN2-027 Study of the Safety and Effectiveness Between

Collagen Matrix Implant and Mitomycin-C in Standard Glaucoma Filtration

Surgery. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,

Indonesia.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 23

72. Shihadeh W A. Efficacy and Safety of Utilizing a Biodegradable Collagen

Matrix Implant in Trabeculectomy. MEACO; March 26-30, 2009, Manama,

Bahrain.

73. Wu Q, Du X, Song B. SP058 Trabeculectomy With ologen Collagen Matrix

Implant: the Treatment Outcomes After Six Month of Follow-up. The 5th

Congress of SEAGIG; September 25-27, 2008, Seoul, Korea.

74. Singh K, Khurana C. SF017 Bleb Characteristics of Subconjunctival

Collagen Implant in Trabeculectomy Compared With Mitomycin Blebs. The

5th Congress of SEAGIG; September 25-27, 2008, Seoul, Korea.

75. Kohlhaas M. DO.16.04 Trabeculectomy With Mitomycin C and ologen. The

106th DOG Congress; September 18-21, 2008, Berlin, Germany.

76. Ozcan AA, Dulger E, Simsek F. Ex-PRESS R-50 Miniature Glaucoma

Implant Insertion Under the Sclera Combined With Mitomycin C and

OculusGen** Application. The XXVI Annual Congress of ESCRS;

September 13-17, 2008, Berlin, Germany.

77. Shihadeh W. Efficacy and Safety of Utilizing A Biodegradable Collagen

Matrix Implant in Trabeculectomy. The XXVI Annual Congress of ESCRS;

September 13-17, 2008, Berlin, Germany.

78. Yuan F, Li L, Chen X, Wang L. Biodegradable 3D-Porous

Collagen-Glycosaminoglycan Scaffold for Treatment of Refractory

Glaucoma. WOC 2008; June 28-July 2, 2008, Hong Kong.

79. Lim BA, Ogle J. GC-D1-166 The Use of Biodegradable Collagen Implant in

Trabeculectomy. WOC 2008; June 28-July 2, 2008, Hong Kong.

80. Grewal SPS, Grewal D, Jain R, Brar GS. GC-D1-188 Adjunct Use of

Biodegradable Porous Collagen-Glycosaminoglycan Implant in

Phacoemulsification Combined With Trabeculectomy for Surgical

Management of Primary Open Angle Glaucoma. WOC 2008; June 28-July 2,

2008, Hong Kong.

81. Kaljurand K. GC-D3-133 Ologen Collagen Matrix Implant in Glaucoma

Filtration Surgery. WOC 2008; June 28-July 2, 2008, Hong Kong.

82. Ali SI, Butt NH. Study of the Safety and Effectiveness Between ologen

Collagen Matrix Implant and Mitomycin-C in Standard Glaucoma Filtration

Surgery. WOC 2008; June 28-July 2, 2008, Hong Kong.

Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 24

83. Jansari P, Porwal M, Hindocha C. Trabeculectomy With Subconjunctival

Biodegradable Implant. WOC 2008; June 28-July 2, 2008, Hong Kong.

Footnotes:

* Before year 2008, there are 26 ologen posters or presentations presented in

the international Conferences.

** OculusGenTM Collagen Matrix has been renamed into ologen® Collagen

Matrix in July 2007. The implants used in this study are OculusGenTM Collagen

Matrix. The material constituents and the physical properties of OculusGenTM

Collagen Matrix has been improved and upgraded for better performance and

efficacy. This becomes ologen® Collagen Matrix. Furthermore, when ologen®

Collagen Matrix is applied in trabeculectomy, loose suture on the sclera flap is

strongly recommended.

Abbreviations: AAO, American Academy of Ophthalmology; APAO,

Asia-Pacific Academy of Ophthalmology; ARVO, Association for Research in

Vision and Ophthalmology; ASCRS, American Society of Cataract and

Refractive Surgery; ASOA, American Society of Ophthalmic Administrators;

DOG, Deutsche Ophthalmologische Gesellschaft; EGS, European Glaucoma

Society; ESCRS, European Society of Cataract and Refractive Surgeons; ICGS,

International Congress on Glaucoma Surgery; MEACO, Middle East African

Council of Ophthalmology; SEAGIG, South East Asia Glaucoma Interest Group;

SOE, European Society of Ophthalmology; WGC, World Glaucoma Congress;

WOC, World Ophthalmology Congress.